Health News Archive - May 18, 2010
SEATTLE, May 18 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTA) reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen.
HOPKINTON, Mass., May 18 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc.
SHENZHEN, China, May 18 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd.
WAYNE, Pa. and LONGFIELD, England, May 18 /PRNewswire/ -- Molecular Detection Inc. (MDI), a company developing Detect-Ready(TM) assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd.
VANCOUVER, May 18 /PRNewswire/ -- The results of forty years of scientific evidence of the benefits of antioxidants and inflammatory response have been poured into YouthJuice(TM) and YouthJuice Restor(TM), two revolutionary new "bio-beverages" just introduced by Our World Network, Inc. Seven varieties of the most potent berries known to science are combined with three types of sea vegetables into a delicious, drinkable, functional food that provides clinically-proven amounts of antioxidants, resveratrol, ellagitannins, fucoidans, and Vitamin D3.
LONDON, May 18 /PRNewswire/ -- There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects.
NORTH LIBERTY, Iowa, May 18 /PRNewswire/ -- KemPharm, Inc. today announced that it has entered into an exclusive Supply Agreement with Johnson Matthey Inc., for the manufacture of the active pharmaceutical ingredient (API), KP201, KemPharm's novel hydrocodone prodrug for acute pain.
HARBIN, China, May 18 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc.
WEBSTER, Texas, May 18 /PRNewswire/ -- IDEV Technologies, Incorporated, (IDEV) an emerging leader in the development and marketing of minimally invasive medical technologies, today announced the European launch of the SUPERA VERITAS(TM) Peripheral Vascular System, a novel and innovative stent delivery system designed to be reliable, easy to use and precise.
HARTFORD, Conn., May 18 /PRNewswire/ -- Dr. Jonathan M. Rothberg, chairman, CEO and founder of Guilford-based Ion Torrent, has been named the 2010 winner of the Connecticut Medal of Technology for his development of innovative genomic technology. Dr.